Shenzhen Hightide Biopharmaceutical, Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Pharmaceutical Composition Comprising Berberine Salts for the Treatment of Various Diseases or Disorders (US 11,685,735) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due May 7, 2027The maintenance fee for Conjugates of islet neogenesis peptides and analogs, and methods thereof (US 11,807,672) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
- 2 fees due Jul 9 to 30, 2027 · next Jul 9
- 1 fee due Nov 7, 2027The maintenance fee for Pharmaceutical Composition Comprising Berberine and Ursodeoxycholic Acid for the Treatment of Various Diseases or Disorders (US 11,976,063) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Nov 3 US 12,778,935 Compositions of Berberine Ursodeoxycholate and Methods Thereof for Treating Fatty Liver Disease, Diabetes and Hyperlipidemia
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,388,215 | Compositions and methods of using islet neogenesis peptides and analogs thereof In force · USPTO record | In force | USPTO record | |
| US 9,738,695 | Compositions and methods of using islet neogenesis peptides and analogs thereof In force · USPTO record | In force | USPTO record | |
| US 11,559,531 | Liquid Formulation Compositions, Medicament Delivery Devices, and Methods of Preparation and Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,976,063 | Pharmaceutical Composition Comprising Berberine and Ursodeoxycholic Acid for the Treatment of Various Diseases or Disorders In force · High confidence | In force | High confidence | |
| US 10,988,471 | Pharmaceutical Composition Comprising Berberine Ursodeoxycholic Acid Salt for the Treatment of Various Diseases or Disorders In force · High confidence | In force | High confidence | |
| US 10,301,303 | Berberine Salts, Ursodeoxycholic Salts and Combinations, Methods of Preparation and Application Thereof In force · High confidence | In force | High confidence | |
| US 11,685,735 | Pharmaceutical Composition Comprising Berberine Salts for the Treatment of Various Diseases or Disorders In force · High confidence | In force | High confidence | |
| US 11,369,573 | Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof In force · USPTO record | In force | USPTO record | |
| US 11,883,539 | Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof In force · USPTO record | In force | USPTO record | |
| US 10,829,527 | Conjugates of islet neogenesis peptides and analogs, and methods thereof In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 17: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 1 abandoned · 9 no status recorded